Indications

• SOBERANA® 02 is indicated for the prevention of symptomatic disease caused by the SARS-CoV-2 virus and severe forms and deaths from COVID-19, in people 2 years of age or older.

Indications

• SOBERANA® PLUS ST is indicated for the prevention of symptomatic disease caused by the SARS-CoV-2 virus, severe forms, and deaths from COVID-19, which can be applied:

1. as the third dose of a heterologous scheme that includes two previous doses with SOBERANA® 02 or SOBERANA® 02 ST, in adults and children from 2 years of age,
2. in people convalescent from COVID-19, adults, and children from 2 years of age, with 2 months or more of their hospital or home medical discharge, or
3. as a booster dose in people previously vaccinated with other vaccines against COVID-19.

Indications

• VA-MENGOC-BC® is indicated for active immunization against meningococcal disease caused by serogroup B and C, from three months of age.
• It is recommended for those persons living in endemic-epidemic areas or traveling to those areas.
• Its administration is recommended to people who live in closed communities, such as daycare centers, boarding schools, military camps, prisons, densely populated areas, and in any community where cases or carriers of serogroups B and C meningococci have been present.

Indications

• vax-SPIRAL® is indicated for active immunization against leptospirosis caused by Canicola serovar canicola, Icterohaemorrhagiae serovar copenhageni y Pomona serovar mozdok, in persons from 15 years old with occupational risk of acquiring the disease, such as miners, veterinarians, animal breeders, farmers, workers in rice and sugar cane plantations, sewage,  slaughterhouses, fish farms, and the army.
• It is indicated in people exposed to water contaminated by urine from domestic and wild animals, bathers, and people camping outdoors in infected areas.
• It is also recommended for people inhabiting risk zones due to the association of elements such as infection by rodents, humid soils, history of morbidity, and the presence and coexistence with domestic and affective animals.

Indications

• vax-MEN-ACW®135 is indicated for active immunization against meningococcal disease caused by serogroup A, C, and W135 in persons over 2 years old. 
• It is particularly recommended for people at risk such as those living or traveling to areas where the disease is either epidemic or highly endemic and for those people in direct contact with patients suffering from meningococcal disease caused by serogroups A, C, or W135.

Indications

• vax-TET® is indicated for active immunization against tetanus in adults and children, in booster vaccination of people who have received the basic immunization scheme, as well as in pregnant women for the prevention of neonatal tetanus. It is also applied in people injured with tetanigenic wounds who have incomplete, unknown, or undocumented immunization.
• It is recommended to vaccinate all people, especially those included in the following groups: patients undergoing surgery, patients with injuries treated in the emergency room, patients with pressure ulcers and/or chronic skin lesions, injecting drug users, pregnant women, elderly people or at work risk of traumatic injuries such as farmers, gardeners, farmers, etc.
• HIV carriers, asymptomatic or not, can be immunized with this vaccine.

Indications

• vax-TyVi® is indicated for the prevention of typhoid fever in adults and children over 2 years of age.
• It is used, especially for those persons exposed to a known carrier, travelers to areas where typhoid fever is endemic, emigrants, medical personnel, military personnel, and any person exposed to Salmonella Typhi infection.

Indications

• diTe-vax® is indicated for the prevention of diphtheria and tetanus in adults. However, it can be used in teenagers and children from 7 years old. 

Indications

• VA-DIFTET® is indicated for the prevention of Tetanus and Diphtheria in children under 7 years of age.
• It is recommended in children with neurological disorders, in whom immunization with the DTP vaccine should be avoided.
• It is also recommended to complete the primary vaccination course in cases where previous DTP doses have caused severe adverse reactions due to the pertussis component.